Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study, Archives of Cancer Science and Therapy, September 2022, Heighten Science Publications Corporation, DOI: 10.29328/journal.acst.1001029.
You can read the full text:
Be the first to contribute to this page